Finger prick blood test trial 'could revolutionise' Alzheimer's diagnosis, say experts
The Bio-Hermes-002 trial enrolls 1,000 volunteers to test a finger-prick blood method detecting three Alzheimer’s biomarkers for earlier, less invasive diagnosis than current standards.
- A study involving 1,000 people aged over 60 aims to detect Alzheimer's disease biomarkers through a finger-prick blood test.
- The study participant Dr Michael Sandberg, whose mother had Alzheimer's, was encouraged to take part after witnessing her decline.
- Experts say early and accurate diagnosis must be a priority for the NHS with new Alzheimer's treatments on the horizon.
25 Articles
25 Articles
Alzheimer's breakthrough as finger-prick blood test could transform diagnosis, scientists say
A major international clinical trial is currently investigating whether a simple finger-prick blood test could transform the way Alzheimer's disease is diagnosed.The Bio-Hermes-002 study spans the United Kingdom, the United States and Canada, and has recruited 1,000 participants aged 60 and above.Researchers are seeking to identify specific biomarkers in the blood that indicate the presence of the degenerative condition.The trial is being coordi…
Coverage Details
Bias Distribution
- 62% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium












